Position in NRIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,747,349
+$650,492 QoQ
Shares Held
72,026
+1.8% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#93
of 210 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NRIX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $3,286,710,193 across 292 Biotechnology names. NRIX ranks #83 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,870,015 | $928,892,550 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
759,971 | $473,872,316 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
924,561 | $278,320,596 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,800,504 | $213,094,258 | |
| 5 | INCY |
Incyte Corp
|
1,605,980 | $182,053,892 | |
| 6 | ARGX |
Argenx SE
|
177,164 | $164,367,443 | |
| 7 | INSM |
INSMED Inc
|
826,431 | $88,114,072 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
381,366 | $71,422,223 |
All Filings in NRIX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,747,349 | 72,026 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,096,857 | 70,765 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $1,612,240 | 84,989 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $766,151 | 82,917 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $710,962 | 62,420 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $696,392 | 58,619 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,138,255 | 60,417 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,345,929 | 59,899 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $1,061,864 | 50,880 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $99,107 | 6,742 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $71,166 | 6,896 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $251,354 | 31,979 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $325,053 | 32,538 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $129,700 | 14,606 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $153,675 | 13,996 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $173,025 | 13,279 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $154,231 | 12,173 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $125,486 | 8,957 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $259,594 | 8,967 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $267,063 | 8,914 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $97,444 | 3,673 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $90,969 | 2,926 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $55,171 | 1,678 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $43,428 | 1,244 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||